Skip to main content

Table 2 Association between platelet inhibitor therapy and history of cancer

From: An association between anti-platelet drug use and reduced cancer prevalence in diabetic patients: results from the Vermont Diabetes Information System Study

Population Multivariate (Adjusted) Analyses*
  N OR (95% CI) P
All subjects 994 0.66 (0.44, 0.99) .045
Women 540 0.63 (0.36,1.08) .09
Men 454 0.71 (0.38,1.32) .29
Age < 65 years 477 0.93 (0.46, 1.90) .85
Age 65 years or more 530 0.61 (0.37, 0.99) .047
Excluding users of non-aspirin inhibitors 925 0.67 (0.44, 1.03) .07
Excluding users of aspirin 525 0.64 (0.22, 1.80) .39
  1. *Adjusted for age, sex, body mass index, presence of ≥ 2 co-morbidities, and number of medications. Body mass index was not available for 13 subjects who were excluded from the multivariate analyses.